These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Collin N; de Radiguès X; Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891 [TBL] [Abstract][Full Text] [Related]
5. Strategies for broad global access to pandemic influenza vaccines. Edwards KM; Sabow A; Pasternak A; Boslego JW Curr Top Microbiol Immunol; 2009; 333():471-93. PubMed ID: 19768420 [TBL] [Abstract][Full Text] [Related]
6. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361 [TBL] [Abstract][Full Text] [Related]
7. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control. Kreijtz JH; Osterhaus AD; Rimmelzwaan GF Hum Vaccin; 2009 Mar; 5(3):126-35. PubMed ID: 18948744 [TBL] [Abstract][Full Text] [Related]
8. New vaccine approaches for seasonal and pandemic influenza. Palache B Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583 [TBL] [Abstract][Full Text] [Related]
9. Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply. Medema JK; Zoellner YF; Ryan J; Palache AM Virus Res; 2004 Jul; 103(1-2):9-15. PubMed ID: 15163482 [TBL] [Abstract][Full Text] [Related]
10. Achieving clinical equality in an influenza pandemic: patent realities. Kane EM Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133 [TBL] [Abstract][Full Text] [Related]
11. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Jennings LC; Monto AS; Chan PK; Szucs TD; Nicholson KG Lancet Infect Dis; 2008 Oct; 8(10):650-8. PubMed ID: 18922487 [TBL] [Abstract][Full Text] [Related]
12. Vaccination for pandemic influenza: a six point agenda for interpandemic years. Fedson DS Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S74-7. PubMed ID: 14730273 [TBL] [Abstract][Full Text] [Related]
13. Norway: problems which a small and sparsely populated European country without a national vaccine production would face during a pandemic. Haaheim LR Eur J Epidemiol; 1994 Aug; 10(4):519-21. PubMed ID: 7843374 [TBL] [Abstract][Full Text] [Related]
14. Preparing for pandemic vaccination: an international policy agenda for vaccine development. Fedson DS J Public Health Policy; 2005 Apr; 26(1):4-29. PubMed ID: 15906873 [TBL] [Abstract][Full Text] [Related]
15. Pandemic influenza and the global vaccine supply. Fedson DS Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755 [TBL] [Abstract][Full Text] [Related]
16. [Influenza vaccine: globalization of public health stakes]. Collin N; Briand S Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377 [TBL] [Abstract][Full Text] [Related]
18. Influenza vaccines: a main problem in control of pandemics. Ghendon Y Eur J Epidemiol; 1994 Aug; 10(4):485-6. PubMed ID: 7843363 [TBL] [Abstract][Full Text] [Related]
19. A global pandemic influenza vaccine action plan. Kieny MP; Costa A; Hombach J; Carrasco P; Pervikov Y; Salisbury D; Greco M; Gust I; LaForce M; Franco-Paredes C; Santos JI; D'Hondt E; Rimmelzwaan G; Karron R; Fukuda K Vaccine; 2006 Sep; 24(40-41):6367-70. PubMed ID: 17240560 [TBL] [Abstract][Full Text] [Related]
20. Vaccines and antiviral drugs in pandemic preparedness. Monto AS Emerg Infect Dis; 2006 Jan; 12(1):55-60. PubMed ID: 16494718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]